SHG — Singular Health Share Price
Last trade - 00:00- AU$71.69m
- AU$67.06m
- AU$0.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 14.94 | ||
| Price to Tang. Book | 15.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 163.39 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -79.46% | ||
| Return on Equity | -162.51% | ||
| Operating Margin | -869.04% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.13 | 0.46 | 0.43 | 0.45 | 0.95 | n/a | n/a | 64.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Singular Health Group Limited is an Australia-based medical technology company. The Company is focused on helping practitioners and patients via personalized surgical planning solutions that drive health outcomes. Its Volumetric Rendering Platform (VRP) leverages existing two-dimensional (2D) radiological images to generate fully immersive patient-specific three-dimensional (3D) models. Its software products include 3DicomViewer, 3DicomVSP, GeoVR and Health Academy. 3Dicom Viewer is a cross-platform application which allows end-users to interact with standard 2D medical images, such as magnetic resonance imaging (MRI) and computerized tomography (CT) scans in 3D. Health Academy has been developed to focus primarily on the year 11 and year 12 Australian Tertiary Admissions Rank (ATAR) human biology courses. 3DicomVSP is a software that underpins the Scan to Surgery approach with the intuitive user-interface providing modules for each of the phases of 3D/ Virtual Reality scan review.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 20th, 2020
- Public Since
- February 12th, 2021
- No. of Shareholders
- 1,975
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 247,214,862
- Address
- Unit 3/26 Railway Road, SUBIACO, 6008
- Web
- https://singular.health/
- Phone
- +61 300167975
- Contact
- James Hill
- Auditors
- Nexia Perth Audit Services Pty Ltd
Latest News for SHG
Upcoming Events for SHG
Similar to SHG
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 23:16 UTC, shares in Singular Health are trading at AU$0.29. This share price information is delayed by 15 minutes.
Shares in Singular Health last closed at AU$0.29 and the price had moved by +208.51% over the past 365 days. In terms of relative price strength the Singular Health share price has outperformed the ASX All Ordinaries Index by +197.33% over the past year.
There is no consensus recommendation for this security.
Find out moreSingular Health does not currently pay a dividend.
Singular Health does not currently pay a dividend.
Singular Health does not currently pay a dividend.
To buy shares in Singular Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.29, shares in Singular Health had a market capitalisation of AU$71.69m.
Here are the trading details for Singular Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: SHG
Based on an overall assessment of its quality, value and momentum Singular Health is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Singular Health. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +235.2%.
As of the last closing price of AU$0.29, shares in Singular Health were trading +84.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Singular Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Singular Health's management team is headed by:
- Denning Chong - NEC
- Thomas Hanly - CEO
- Kwang Guan Tay - EDR
- Steven Wood - SEC
- Howard Digby - DRC
- Andrew Just - DRC